Vaccines to treat opioid use disorders and to reduce opioid overdoses
Neuropsychopharmacology
.
2019 Jan;44(1):217-218.
doi: 10.1038/s41386-018-0197-3.
Authors
Carly Baehr
1
2
,
Marco Pravetoni
3
4
Affiliations
1
Department of Veterinary Population Medicine, University of Minnesota, St. Paul, MN, USA.
2
Hennepin Healthcare Research Institute (formerly Minneapolis Medical Research Foundation), Minneapolis, MN, USA.
3
Hennepin Healthcare Research Institute (formerly Minneapolis Medical Research Foundation), Minneapolis, MN, USA.
[email protected]
.
4
Departments of Medicine and Pharmacology, Center for Immunology, University of Minnesota, Minneapolis, MN, USA.
[email protected]
.
PMID:
30405185
PMCID:
PMC6235930
DOI:
10.1038/s41386-018-0197-3
No abstract available
Publication types
News
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Drug Overdose / prevention & control*
Humans
Opioid-Related Disorders / therapy*
Vaccines
Substances
Vaccines
Grants and funding
T32 DA007097/DA/NIDA NIH HHS/United States
R01 DA041730/DA/NIDA NIH HHS/United States
R01 DA041730/U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA)/International
U01 DA038876/U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA)/International
U01 DA038876/DA/NIDA NIH HHS/United States